Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Jaundice01:25

Jaundice

34
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
34
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.1K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

5.6K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

409
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Portal Hypertension01:22

Portal Hypertension

50
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
50

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Quality of Life, Anxiety and Depressive Symptoms in Serbian Children with Celiac Disease and their Parents.

Indian journal of pediatrics·2019
Same author

Novel genetic risk variants for pediatric celiac disease.

Human genomics·2016
Same author

Food allergy in children.

Srpski arhiv za celokupno lekarstvo·2016
Same author

Acute Diarrhea in Children.

Srpski arhiv za celokupno lekarstvo·2016
Same author

Celiac crisis in children in Serbia.

Italian journal of pediatrics·2016
Same author

Case report of acute vitamin D intoxication in an infant.

Srpski arhiv za celokupno lekarstvo·2015

Related Experiment Video

Updated: Apr 29, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

7.6K

Hereditary hyperbilirubinemias.

Nedeljko Radlović

    Srpski Arhiv Za Celokupno Lekarstvo
    |May 21, 2014
    PubMed
    Summary

    Inherited bilirubin metabolism disorders include Gilbert, Crigler-Najjar, Dubin-Johnson, and Rotor syndromes. Most are benign, with Gilbert syndrome being common and others rare, generally requiring no treatment.

    Area of Science:

    • Medical Genetics
    • Biochemistry
    • Hepatology

    Background:

    • Inherited disorders of bilirubin metabolism are genetic conditions affecting liver function.
    • These disorders are typically inherited in an autosomal recessive pattern.
    • They manifest as hyperbilirubinemia, categorized by unconjugated or conjugated forms.

    Purpose of the Study:

    • To outline the spectrum of inherited bilirubin metabolism disorders.
    • To differentiate between disorders causing unconjugated and conjugated hyperbilirubinemia.
    • To provide an overview of the prevalence and clinical significance of these conditions.

    Main Methods:

    • Review of established genetic and biochemical classifications of bilirubin metabolism disorders.
    • Analysis of population prevalence data for Gilbert syndrome and other rare inherited hyperbilirubinemias.

    More Related Videos

    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
    10:56

    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

    Published on: September 15, 2018

    7.5K
    Measurement of Heme Synthesis Levels in Mammalian Cells
    09:43

    Measurement of Heme Synthesis Levels in Mammalian Cells

    Published on: July 9, 2015

    11.4K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
    09:54

    Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

    Published on: November 4, 2018

    7.6K
    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
    10:56

    A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

    Published on: September 15, 2018

    7.5K
    Measurement of Heme Synthesis Levels in Mammalian Cells
    09:43

    Measurement of Heme Synthesis Levels in Mammalian Cells

    Published on: July 9, 2015

    11.4K
  • Clinical characterization based on bilirubin conjugation status.
  • Main Results:

    • Four main autosomal recessive syndromes identified: Gilbert, Crigler-Najjar, Dubin-Johnson, and Rotor.
    • Gilbert and Crigler-Najjar syndromes present with unconjugated hyperbilirubinemia.
    • Dubin-Johnson and Rotor syndromes present with conjugated hyperbilirubinemia.
    • Gilbert syndrome affects 2%-10% of the population; others are rare.
    • Hereditary hyperbilirubinemias, excluding Crigler-Najjar syndrome, are benign and require no treatment.

    Conclusions:

    • Inherited bilirubin disorders represent a group of genetic conditions with varying clinical impact.
    • Understanding the specific syndrome is crucial for accurate diagnosis and prognosis.
    • Most hereditary hyperbilirubinemias are benign, highlighting the importance of distinguishing them from more severe liver diseases.